Top Cancer Stocks in South Korea
Browse the largest South Korea companies in the world ranked by their Market Capitalization. Global Cancer Companies in South Korea market cap is $0.
19 Dec 2024, 15:54 UTC
Companies: 0
🇰🇷1 |  | $185.90 | -1.28% | 2.36B | -23.62% | Underperform S&P500 YTD Benchamark | 💊 Pharma | - |
🇰🇷2 |  | $49.16 | -5.05% | 1.40B | -13.03% | Underperform S&P500 YTD Benchamark | 🦾 AI | - |
🇰🇷3 |  | $18.83 | -5.20% | 901.87M | 10.06% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷4 |  | $1.30 | -0.79% | 180.07M | -21.87% | Underperform S&P500 YTD Benchamark | 💊 Pharma | - |
🇰🇷5 |  | $3.83 | -4.30% | 158.68M | -44.40% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷6 |  | $7.19 | -2.61% | 145.33M | -54.41% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷7 |  | $1.77 | 0.79% | 124.56M | -57.46% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷8 |  | $4.92 | -2.72% | 92.63M | -14.78% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷9 |  | $2.25 | 29.82% | 62.76M | -24.77% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷10 |  | $4.20 | -0.97% | 58.19M | -48.65% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷11 |  | $3.79 | -7.25% | 51.51M | 23.04% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷12 |  | $4.60 | 0.00% | 35.97M | N/A | S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷13 |  | $1.01 | -2.14% | 33.42M | -44.61% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷14 |  | $0.46 | -6.99% | 24.17M | -44.58% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷15 |  | $0.83 | -4.60% | 14.63M | -43.57% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷16 |  | $1.38 | -2.30% | 10.03M | -40.36% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
